Hexo (TSX:HEXO) Stock Is up 123% Year to Date: Is This Sustainable?

Canopy Growth Corp (TSX:WEED)(NYSE:CGC) remains the cannabis stock to own for the long term, but Hexo Corp. (TSX:HEXO) is quickly making a name for itself in the edibles market.

| More on:
Knowledge concept with quote written on wooden blocks

Image source: Getty Images

$2.1 billion Hexo (TSX:HEXO) can be classified as one of the many cannabis companies that are flying high in a race to capture as much of the multi-billion cannabis market as possible.

With a product offering including pre-rolls, flower, oil, and decarb products, the company has 1.8 million square feet of facilities in Ontario and Quebec and is working hard toward its goal of becoming the premier-branded cannabis company in the edibles space.

As such, Hexo recently acquired Newstrike Brands in an all-stock deal worth $260 million. This combination will mean Hexo will experience an increase in size and reach, and Hexo will have a clear path toward creating specialty products for the edibles market.

In addition to this, in 2018, Hexo announced a partnership with Molson Coors, a joint venture that will be focused on non-alcoholic, cannabis-infused beverages for the Canadian market.

The consumable cannabis market, which is expected to be legalized later this year, is another potentially lucrative market that cannabis companies are working to get a foothold in.

Hexo is well positioned here.

$22.4 billion Canopy Growth (TSX:WEED)(NYSE:CGC) stock has rallied 80% year to date, as this company continues to demonstrate why it is the top cannabis stock to own.

With 4.3 million square feet in operating in Canada, partnerships such as the Constellations Brands partnership, as well as success in its global expansion and 32 patents in its growing intellectual property portfolio of products and technologies, Canopy is a force to be reckoned with.

Taking stock on sustainability

This is all extremely exciting for the long-term viability of the cannabis industry and these two cannabis stocks, but in the short term, where do we stand in terms of sustaining these stock price gains?

Trading at exorbitant price-to-sales multiples, with escalating net losses and growth spending, I can see how these stocks and cannabis stocks in general have big downside in the short term.

Yes, the stocks can grow into these valuations in the long term, but I continue to caution that the short term is fraught with risks for these stock prices.

Aurora Cannabis will be reporting its results on May 14, with Canopy reporting in June, and as these results keep rolling in, we will continue to get a clearer picture on the state of the market and company fundamentals.

Final thoughts

Cannabis stocks remain highly volatile, so your best bet is to take some profits in times of strength (like today) and buy on weakness after a market correction.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Karen Thomas has no position in any of the stocks mentioned. The Motley Fool owns shares of Molson Coors Brewing.

More on Cannabis Stocks

A cannabis plant grows.
Cannabis Stocks

TLRY Stock: Here’s What’s Coming in 2023

Tilray Inc. (TSX:TLRY) is geared up for big growth this decade and looks like one of the top cannabis stocks…

Read more »

A person holds a small glass jar of marijuana.
Cannabis Stocks

Canopy Growth Stock: Here’s What’s Coming in 2023

Canopy Growth stock has made a lot of new moves in the last few months, but where is the company…

Read more »

A cannabis plant grows.
Cannabis Stocks

Better Cannabis Buy: Canopy Growth Stock or Tilray?

Only two TSX weed stocks can deliver substantial returns in the highly anticipated growth of the global cannabis market.

Read more »

Medicinal research is conducted on cannabis.
Cannabis Stocks

Is Tilray Stock a Buy in January 2023?

Tilray stock has lost 50% of its value in the last 12 months, in line with its peers.

Read more »

Pot stocks are a riskier investment
Cannabis Stocks

Are Cannabis Stocks Still a Thing in 2023?

The whole question of whether cannabis stocks are still relevant in 2023 is an interesting one. Here's my take on…

Read more »

A cannabis plant grows.
Cannabis Stocks

Why Canopy Growth Stock Fell 72% Last Year

Canopy Growth stock is a beaten-up cannabis giant that is trading at a discount compared to historical multiples. But is…

Read more »

Cannabis grows at a commercial farm.
Cannabis Stocks

Is SNDL Stock a Buy in January 2023?

SNDL is among the worst-performing cannabis stocks in the last three years. But is SNDL stock a buy right now?

Read more »

a person watches a downward arrow crash through the floor
Cannabis Stocks

Why Tilray Stock Fell Almost 60% in 2022

Tilray is a Canadian cannabis stock that is down 93% from all-time highs. Let's see if TLRY stock is a…

Read more »